Attention Deficit Disorder with Hyperactivity

8 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Attention Deficit Disorder with Hyperactivity
Treatment and conditionWhere it standsTrials
Academic Competency Enhancement (ACE) classroom for attention deficit disorder with hyperactivityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
EB-1020 (Centanafadine) high dose for attention deficit disorder with hyperactivityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
EB-1020 (Centanafadine) low dose for attention deficit disorder with hyperactivityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fecal Microbiota Transplant (FMT) for attention deficit disorder with hyperactivityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Fecal Microbiota Transplant (FMT) + Vancomycin + NITAZOXANIDE for attention deficit disorder with hyperactivityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Lysergide d-tartrate for attention deficit disorder with hyperactivityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Vancomycin + NITAZOXANIDE for attention deficit disorder with hyperactivityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Viloxazine hydrochloride for attention deficit disorder with hyperactivityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)5